These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 7601266)

  • 41. Long-term survival followed by degradation of neurofilament proteins in severed mauthner axons of goldfish.
    Moehlenbruck JW; Cummings JA; Bittner GD
    J Neurobiol; 1994 Dec; 25(12):1637-51. PubMed ID: 7861125
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Blood-nerve barrier in the frog during wallerian degeneration: are axons necessary for maintenance of barrier function?
    Latker CH; Wadhwani KC; Balbo A; Rapoport SI
    J Comp Neurol; 1991 Jun; 308(4):650-64. PubMed ID: 1865020
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Wallerian degeneration in the optic nerve of the wabbler-lethal (wl/wl) mouse.
    Carroll EW; Curtis RL; Sullivan DA; Melvin JL
    Brain Res Bull; 1992; 29(3-4):411-8. PubMed ID: 1382814
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CHANGES IN THE ENDONEURIAL SHEATHS OF PERIPHERAL MYELINATED NERVE FIBRES DURING WALLERIAN DEGENERATION.
    THOMAS PK
    J Anat; 1964 Apr; 98(Pt 2):175-82. PubMed ID: 14154420
    [No Abstract]   [Full Text] [Related]  

  • 45. Difference in the morphology of Wallerian degeneration in the central nervous system (CNS) and peripheral nervous system (PNS) and its effect on regeneration.
    Wisniewski HM
    Birth Defects Orig Artic Ser; 1983; 19(4):389-95. PubMed ID: 6871406
    [No Abstract]   [Full Text] [Related]  

  • 46. Schwann cells degrade myelin and proliferate in the absence of macrophages: evidence from in vitro studies of Wallerian degeneration.
    Fernandez-Valle C; Bunge RP; Bunge MB
    J Neurocytol; 1995 Sep; 24(9):667-79. PubMed ID: 7500122
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Application of electron immunocytochemistry to the study of distribution of myelin-associated glycoprotein in the early period of Wallerian degeneration in the optic system.
    Goncerzewicz A
    Neuropatol Pol; 1983; 21(3):343-52. PubMed ID: 6363972
    [No Abstract]   [Full Text] [Related]  

  • 48. Temporal and spatial expression of ciliary neurotrophic factor after peripheral nerve injury.
    Smith GM; Rabinovsky ED; McManaman JL; Shine HD
    Exp Neurol; 1993 Jun; 121(2):239-47. PubMed ID: 8339774
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adhesive/repulsive properties in the injured spinal cord: relation to myelin phagocytosis by invading macrophages.
    Frisén J; Haegerstrand A; Fried K; Piehl F; Cullheim S; Risling M
    Exp Neurol; 1994 Oct; 129(2):183-93. PubMed ID: 7957733
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Myelin from peripheral and central nervous system is a nonpermissive substrate for retinal ganglion cell axons.
    Bähr M; Przyrembel C
    Exp Neurol; 1995 Jul; 134(1):87-93. PubMed ID: 7672041
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of continuous and intermittent vibration effects on rat-tail artery and nerve.
    Govindaraju SR; Curry BD; Bain JL; Riley DA
    Muscle Nerve; 2006 Aug; 34(2):197-204. PubMed ID: 16691604
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Axons modulate the expression of transforming growth factor-betas in Schwann cells.
    Scherer SS; Kamholz J; Jakowlew SB
    Glia; 1993 Aug; 8(4):265-76. PubMed ID: 8406683
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Schwann cell properties: 3. C-fos expression, bFGF production, phagocytosis and proliferation during Wallerian degeneration.
    Liu HM; Yang LH; Yang YJ
    J Neuropathol Exp Neurol; 1995 Jul; 54(4):487-96. PubMed ID: 7602323
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Involvement of monocyte chemoattractant protein-1, macrophage inflammatory protein-1alpha and interleukin-1beta in Wallerian degeneration.
    Perrin FE; Lacroix S; Avilés-Trigueros M; David S
    Brain; 2005 Apr; 128(Pt 4):854-66. PubMed ID: 15689362
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of Schmidt-Lanterman incisures in Wallerian degeneration. I. A quantitative teased fibre study.
    Ghabriel MN; Allt G
    Acta Neuropathol; 1979 Nov; 48(2):93-93. PubMed ID: 506700
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of pyrethroid molecules on rat nerves in vitro: potential to reverse temperature-sensitive conduction block of demyelinated peripheral axons.
    Lees G
    Br J Pharmacol; 1998 Feb; 123(3):487-96. PubMed ID: 9504390
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quantitative and qualitative analysis of Wallerian degeneration using restricted axonal labelling in YFP-H mice.
    Beirowski B; Berek L; Adalbert R; Wagner D; Grumme DS; Addicks K; Ribchester RR; Coleman MP
    J Neurosci Methods; 2004 Mar; 134(1):23-35. PubMed ID: 15102500
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tenascin-C expression during wallerian degeneration in C57BL/Wlds mice: possible implications for axonal regeneration.
    Fruttiger M; Schachner M; Martini R
    J Neurocytol; 1995 Jan; 24(1):1-14. PubMed ID: 7539482
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Light and electron microscopic assessment of progressive atrophy following moderate traumatic brain injury in the rat.
    Rodriguez-Paez AC; Brunschwig JP; Bramlett HM
    Acta Neuropathol; 2005 Jun; 109(6):603-16. PubMed ID: 15877231
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Local administration of thyroid hormones in silicone chamber increases regeneration of rat transected sciatic nerve.
    Voinesco F; Glauser L; Kraftsik R; Barakat-Walter I
    Exp Neurol; 1998 Mar; 150(1):69-81. PubMed ID: 9514821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.